Novo Nordisk AS

NVO

Novo Nordisk AS News & Analysis

stocks

2 companies poised to capitalize on the rise of GLP-1 drugs

Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
markets

December 2025 US stock market outlook: Where we see investment opportunities

Heading into year-end, Santa Claus Rally or AI exhaustion?
stocks

3 ‘buy the dip’ candidates with wide moats

Does recent share price weakness spell opportunity in these three high-quality companies?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,712.8044.300.51%
CAC 407,705.1564.16-0.83%
DAX 4022,295.58317.39-1.40%
Dow JONES (US)45,603.48356.63-0.78%
FTSE 1009,954.8017.37-0.17%
HKSE24,951.8895.450.38%
NASDAQ21,146.28261.80-1.22%
Nikkei 22553,373.07230.58-0.43%
NZX 50 Index12,935.3941.60-0.32%
S&P 5006,424.7952.37-0.81%
S&P/ASX 2008,516.3044.700.53%
SSE Composite Index3,913.7224.640.63%

Market Movers